mortality/aging
|
• 3 weeks after tamoxifen treatment
|
hematopoietic system
|
• tamoxifen-treated mice exhibit impaired erythroid development at multiple stages
|
|
• after tamoxifen treatment
|
|
• after tamoxifen treatment
|
|
• after tamoxifen treatment
|
|
• after tamoxifen treatment
|
|
• after tamoxifen treatment
|
pancytopenia
(
J:231701
)
|
• severe in adult mice treated with tamoxifen
|
|
• cell-autonomous impairment of hematopoietic stem cell function with activation of unfolded protein response and cell death after tamoxifen treatment
|
embryo
|
• tamoxifen-treated mice exhibit impaired erythroid development at multiple stages
|
growth/size/body
weight loss
(
J:231701
)
|
• after tamoxifen treatment
|
immune system
|
• after tamoxifen treatment
|
|
• after tamoxifen treatment
|
|
• after tamoxifen treatment
|


Analysis Tools